Update on micronutrients and cervical dysplasia

Ethnicity and Disease

Volumn 17, Issue 2, 2007, Pages

  Piyathilake, Chandrika J ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Cervix; Folate; HPV; Neoplasia

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; BETA CAROTENE; BETA CRYPTOXANTHIN; CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE; LYCOPENE; RETINOL; TRACE ELEMENT;

CARCINOGENESIS; COLPOSCOPY; CONFERENCE PAPER; CYTOLOGY; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC ERROR; DIET SUPPLEMENTATION; DISEASE ASSOCIATION; FEMALE; FOLIC ACID DEFICIENCY; HUMAN; METHODOLOGY; PATIENT PARTICIPATION; PRECANCER; RISK ASSESSMENT; RISK FACTOR; UTERINE CERVIX BIOPSY; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX DYSPLASIA; VIRUS INFECTION; VIRUS STRAIN; WART VIRUS;

FEMALE; HUMANS; MICRONUTRIENTS; PAPILLOMAVIRUS INFECTIONS; UNITED STATES; UTERINE CERVICAL DYSPLASIA;

EID: 34447529122     PISSN: 1049510X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (19)

1. Potischman N, Brinton LA. Nutrition and cervical neoplasia. Cancer Causes Control. 1996;7:113-126.
2. Garcia-Closas R, Castellsague X, Bosch X, Gonzalez CA. The role of diet and nutrition in cervical carcinogenesis: a review of recent evidence. Int J Cancer. 2005;117(4):629-637.
3. Sedjo RL, Papenfuss MR, Craft NE, Giuliano AR. Effect of plasma micronutrients on clearance of oncogenic human papillomavirus (HPV) infection (United States). Cancer Causes Control. 2003;14:319-326.
4. Giuliano AR, Papenfuss M, Nour M, Canfield LM, Schneider A, Hatch K. Antioxidant nutrients: associations with persistent human papillomavirus infection. Cancer Epidemiol Biomarkers Prev. 1997;6:917-923.
5. Sedjo RL, Inserra P, Abrahamsen M, Harris RB, Roe DJ, Baldwin S. Human papillomavirus persistence and nutrients involved in the methylation pathway among a cohort of young women. Cancer Epidemiol Biomarkers Prev. 2002;11:353-359.
6. Sedjo RL, Fowler BM, Schneider A, Henning SM, Hatch K, Giuliano AR. Folate, vitamin B12, and homocysteine status. Findings of no relation between human papillomavirus persistence and cervical dysplasia. Nutrition. 2003;19:497-502.
7. Palan PR, Chang CJ, Mikhail MS, Ho GY, Basu J, Romney SL. Plasma concentrations of micronutrients during a nine-month clinical trial of beta-carotene in women with precursor cervical cancer lesions. Nutr Cancer. 1998;30: 46-52.
8. Piyathilake CJ, Henao OL, Macaluso M, et al. Folate is associated with the natural history of high-risk human papillomaviruses. Cancer Res. 2004;64:8788-8793.
9. Chandra S, Chandra RK. Nutrition, immune response, and outcome. Prog Food Nutr Sci. 1986;10:1-65.
10. Dhut A, Galan P, Hercberg S. Folate status and the immune system. Prog Food Nutr Sci. 1991;15:43-60.
11. Wilke CM, Hall BK, Hoge A, Paradee W, Smith DI, Glover TW. FRA3B extends over a broad region and contains a spontaneous HPV 16 integration site: direct evidence for the coincidence of vital integration sites and fragile sites. Hum Mol Genet. 1996;5:187-195.
12. Popescu NC, DiPaolo JA, Amsbaugh SC. Integration sites of human papillomavirus 18 DNA sequences on HeLa cell chromosomes. Cytogenet Cell Genet. 1987;44:58-62.
13. Pillai MR, Chacko P, Kesari LA, Jayaprakash PG, Jayaram HN, Antony AC. Expression of folate receptors and heterogeneous nuclear ribonucleoprotein E1 in women with human papillomavirus mediated transformation of cervical tissue to cancer. J Clin Pathol. 2003; 56(8):569-574.
14. Munoz N, Bosch FX, de Sanjose S, et al. Epidemiologic dassification of human papillomavirus types associated with cervical cancer. N Engl J Med. 2003;348(6):518-527.
15. Rothman KJ, Greenland S. Modern Epidemiology. 2nd ed. Philadelphia: Lippincott-Raven; 1998.
16. ASCUS-LSIL Traige Study (ALTS) Group. Results of a randomized trial on the management of cytology interpretations of atypical squamous cells of undetermined significance. Am J Obstet Gynecol. 2003;188(6):1383-1392.
17. ASCUS-LSIL Traige Study (ALTS) Group. A randomized trial on the management of low-grade squamous intraepithelial lesion cytology interpretations. Am J Obstet Gynecol. 2003; 188(6):1393-1400.
18. Butterworth CE Jr, Hatch KD, Soong SJ, et al. Oral folic acid supplementation for cervical dysplasia: a clinical intervention trial. Am J Obstet Gynecol. 1992;166:803-809.
19. Childers JM, Chu J, Voigt LF, et al. Chemoprevention of cervical cancer with folic acid: a phase III Southwest Oncology Group Intergroup study. Cancer Epidemiol Biomarkers Prev. 1995;4:155-159.